CHANGSHA, Nov 7, 2025 — Hunan Xianshi Pharmaceutical Co., Ltd. will participate in the 91st National Pharmaceutical Fair from November 19 to 21. Its exhibition booth is located at Booth 8E28-2, Hall 8, where the company will display a complete lineup of core commercial products and pipeline candidates.

Preview of Core Exhibited Products for Cooperation

1. Gudeli® Vitamin D3 Injection

Class A unrestricted national medical insurance product, applicable across all clinical departments and recommended for the elderly, pregnant women, postpartum females and children.

Product Advantages

It is recommended by domestic and international guidelines for prevention and treatment of vitamin D deficiency.

- Vitamin D3 features 5 to 10 times higher bioavailability than vitamin D2

- Vitamin D2 contains more impurities with relatively higher toxic risk

- Intermittent high-dose supplementation improves medication adherence compared with long-term daily low-dose intake

Indications & Applicable Departments

For prevention and treatment of vitamin D deficiency in vegetarians, parenteral nutrition recipients, patients with pancreatic insufficiency, hepatobiliary disorders, intestinal diseases or post-gastrectomy conditions.

It also treats chronic hypocalcemia, hypophosphatemia, renal osteomalacia, familial hypophosphatemia and multiple types of hypoparathyroidism, as well as various forms of tetany.

Applicable to orthopedics, endocrinology, immunology, nephrology, obstetrics and gynecology, hematology, oncology, geriatrics, pediatrics, gastroenterology, pulmonology, cardiology and neurology.

 

2. Nitrogen Mustard Hydrochloride Injection

Exclusive formulation covered by unrestricted Class A national medical insurance, used as a fundamental anti-tumor agent to lower recurrence risk.

Product Advantages

- Limited clinical application over the past 20 years leads to low drug resistance incidence

- As a non-cell-cycle specific alkylating agent, it delivers fast onset and strong anti-tumor activity and acts on resting G0-phase tumor cells to reduce recurrence root causes

- Suitable for combination therapy with ASCT, targeted or immunotherapy to improve efficacy, reduce toxicity and lower relapse rate

Indications & Applicable Departments

Mainly indicated for malignant lymphoma including Hodgkin’s disease; intracavitary administration controls malignant cavity effusions in pleura, pericardium and peritoneum.

Used in hematology, oncology, gastroenterology and respiratory medicine.

 

3. National Centralized Procurement Listed Products

Procaterol Hydrochloride Inhalation Solution

Shortlisted in the 11th national volume-based procurement (Henan, Hebei, Yunnan, Beijing, Chongqing, Liaoning, Qinghai), Class B national medical insurance.

Product Advantages

Onset within 5 minutes with over 8 hours of sustained effect; high β2 receptor selectivity minimizes cardiac adverse reactions such as palpitation and tremor.

Independent of active inhalation effort, suitable for weak elderly patients and those with liver or renal dysfunction. It is listed as guideline first-line therapy for asthma.

Indications & Applicable Departments

Relieves airflow limitation symptoms of bronchial asthma, chronic bronchitis and emphysema. Used in pediatrics, respiratory medicine, surgery, cardiothoracic department, emergency, ICU and geriatrics.

Roxadustat Capsules: 

11th national procurement winner (Hunan, Chongqing, Qinghai), Class B medical insurance.

Product Advantages

High hemoglobin improvement rate for dialysis-related anemia; stable efficacy under inflammatory status, reduces hepcidin to optimize iron metabolism and cuts need for regular IV iron supplementation; lower cardiovascular risk versus ESAs; oral room-temperature storage improves compliance.

Indications & Applicable Departments

Anemia induced by chronic kidney disease for both dialysis and non-dialysis patients; applicable to nephrology, hematology, cardiology, endocrinology and geriatrics.

Avatrombopag Maleate Tablets

11th national procurement product (Guangdong, Hunan, Yunnan, Inner Mongolia), Class B medical insurance.

Product Advantages

One of few oral TPO-RAs approved for both CLDT and ITP indications; next-generation non-peptide small molecule without neutralizing antibody induction, no food limitation and favorable liver safety profile, effectively elevates platelet count and reduces bleeding risk.

Indications & Applicable Departments

Preoperative thrombocytopenia for chronic liver disease patients; refractory primary immune thrombocytopenia in adults unresponsive to conventional therapy. Used in hematology, hepatology, general surgery, gastroenterology and interventional departments.

Peramivir Injection

10th national procurement product (primary supply: Yunnan, Guangdong, Guangxi; backup: Jiangsu, Liaoning, Beijing).

Product Advantages

High-concentration small-volume ampoule enables flexible individualized dosage adjustment compared with large-volume peramivir infusion; can be diluted with glucose injection for sodium-restricted patients to provide extra energy.

Indications & Applicable Departments

Treatment of Influenza A and B; used in emergency, infectious disease, respiratory critical care, pediatrics and fever clinics.

 

4. Phloroglucinol Orally Disintegrating Tablets

A preferred European medication for spastic pain in women and children.

Product Advantages

Relaxes smooth muscle spasm across digestive, biliary, urinary and reproductive systems with few contraindications for pregnant women, elderly and children.

Onset in 15–20 minutes with 4-hour duration; high bioavailability close to injectable forms.

No anticholinergic side effects, safe for glaucoma, BPH, intestinal obstruction and cardiac patients; water-free intake fits preoperative fasting patients.

Indications & Applicable Departments

Acute visceral spasm pain in digestive, biliary, urinary and gynecological systems; adjuvant use for gestational uterine contraction. Used in emergency, obstetrics and gynecology, urology, gastroenterology and pediatrics.

 

5. Oseltamivir Phosphate Granules

Class B national medical insurance, guideline first-line anti-influenza drug.

Product Advantages

Original Japanese dry syrup formula with good solubility and fruit flavor; wider approved age range for treatment (≥2 weeks old) and prevention (≥1 year old).

Equipped with exclusive four-piece dosing tool for precise weight-based administration for infants; large 0.9g specification meets full treatment cycle dosage.

Indications & Applicable Departments

Treatment of Influenza A/B for patients ≥2 weeks old; prevention for individuals ≥1 year old. Applied in emergency, infectious disease, respiratory, pediatrics and ICU.

 

6. Alpha-lipoic Acid Tablets

Guideline-recommended antioxidant medicine targeting oxidative stress.

Product Advantages

Supports both etiological and symptomatic management of diabetic peripheral neuropathy by improving oxidative stress and relieving clinical symptoms.

Indications & Applicable Departments

Sensory abnormality from diabetic peripheral neuropathy; applicable to endocrinology, neurology, nephrology, cardiology, ophthalmology and otolaryngology.

 

7. Preview of Upcoming Key Pipeline Products

- Topiramate Tablets: suitable for gout patients with renal insufficiency

- Teriparatide Injection: FDA-approved agent for osteoblast proliferation

- Mannitol-Sorbitol Injection: essential routine and emergency clinical medicine

More new products will be unveiled on site.

Xianshi Pharmaceutical welcomes all industry clients and partners to visit Booth 8E28-2, Hall 8 during the fair. The company aims to build long-term win-win strategic partnerships via in-depth communication and joint development for mutual growth.